USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-02-28 обновлены отчеты компании FOLD: 202320222021
Amicus Therapeutics logo
Amicus Therapeutics FOLD
$ 10.28 1.08%

Amicus Therapeutics Мультипликаторы 2011-2024 | FOLD

Мультипликаторы по годам Amicus Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-25.5 -16.7 -10.2 -17.7 -6.1 -6.2 -8.7 -6.1 -5.0 -8.3 -2.4 -3.4 -5.1

P/S

9.7 12.0 8.4 18.8 12.0 23.8 66.6 246.0 - 467.7 399.8 9.1 10.5

EPS

-0.5 -0.8 -0.9 -1.1 -1.5 -1.9 -1.9 -1.5 -1.2 -0.9 -1.2 -1.1 -1.3

EV (Enterprise Value)

4.23 млрд 4.4 млрд 2.91 млрд 5.33 млрд 2.41 млрд 2.54 млрд 2.68 млрд 1.03 млрд 1.16 млрд 636 млн 183 млн 174 млн 240 млн

EBITDA per Share

-0.23 -0.72 -0.74 -0.92 -1.23 -1.73 -1.35 -0.791 -1.13 -0.902 -1.18 -1.12 -1.43

EV/EBITDA

-14.0 -21.8 -7.4 -7.5 -12.4 -6.8 -5.1 -8.4 -1.9 -2.6 -4.1

PEG

0.88 1.72 -2.03 -6.0 -0.29 3.83 0.36 -0.23 0.17 -0.42 0.29 -0.21 -0.14

P/B

24.1 32.1 8.3 17.1 4.6 6.3 7.0 - 1.9 4.7 3.2 2.4 7.6

P/CF

-55.9 -23.7 -12.6 -21.0 -8.1 -7.1 -11.2 -7.8 -6.3 -11.0 -3.1 -4.4 -4.4

ROE %

-94.64 -192.26 -81.49 -96.67 -74.80 -101.77 -80.49 - -37.98 -56.41 -130.34 -70.48 -150.08

ROA %

-19.49 -32.67 -27.67 -31.23 -41.92 -44.18 -45.29 - -14.54 -32.83 -46.75 -44.31 -63.63

ROCE %

-48.20 -172.39 -67.16 -86.25 -41.69 -46.24 -37.86 - -15.10 -36.18 -53.11 -52.49 -100.69

Current Ratio

1.3 1.2 1.5 1.5 4.0 6.4 5.6 - 2.9 7.7 8.4 11.3 3.5

DSO

70.3 65.9 59.5 56.1 66.7 87.9 93.5 - - - 763.2 63.9 85.9

DIO

408.3 239.4 245.6 197.5 233.3 212.6 270.6 - - - - - -

DPO

149.3 174.6 204.3 228.0 361.0 167.4 460.5 - - - - - -

Операционный цикл

478.6 305.3 305.1 253.6 300.0 300.5 364.1 - - - - - -

Финансовый цикл

329.3 130.7 100.8 25.6 -61.0 133.1 -96.3 - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Amicus Therapeutics

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.07 -0.15 -0.18 - -0.12 -0.21 -0.3 - -0.19 -0.19 -0.25 -0.27 -0.25 -0.2 -0.35 -0.35 -0.24 -0.36 -0.56 -0.43 -0.84 -0.33 -0.28 -0.42 -0.69 -0.34 -0.39 -0.41 -0.33 -0.4 -0.35 -0.34 -0.32 -0.27 -0.25 -0.24 -0.22 -0.22 -0.25 -0.22 -0.29 -0.31 -0.35 -0.2 -0.34 -0.2 -0.35 -0.25 -0.28 -0.37 -0.39

EBITDA per Share

-0.05 -0.06 -0.12 - -0.11 -0.2 -0.26 - -0.15 -0.14 -0.19 - -0.19 -0.19 -0.3 - -0.22 -0.32 -0.38 - -0.82 -0.24 -0.31 - -1.71 -0.32 -0.36 - -0.31 -0.37 -0.34 - -0.32 -0.27 -0.25 - -0.21 -0.21 -0.24 - -0.3 -0.31 -0.34 - -0.34 -0.19 -0.27 - -0.36 -0.41 -0.28

ROE %

-131.65 -140.57 -137.66 -96.68 -110.03 -98.28 -86.39 -63.47 -88.40 -97.40 -91.79 -96.67 -90.57 -81.20 -80.61 -74.80 -78.74 -112.18 -112.47 -101.77 -98.62 -83.85 -79.46 -80.49 -77.16 -58.47 -59.00 -55.54 -51.59 -49.51 -43.13 -37.98 -43.02 -46.19 -50.35 -56.41 -65.79 -83.65 -105.23 -130.34 -118.06 -109.71 -89.66 -70.48 -85.28 -94.73 -123.95 -150.08 -32.98 -42.72 -45.11

ROA %

-20.68 -22.24 -26.63 -25.00 -30.26 -20.82 -27.33 -19.87 -27.93 -29.89 -29.30 -31.23 -33.73 -33.78 -37.80 -41.92 -41.25 -54.13 -52.01 -44.18 -45.33 -42.99 -42.84 -45.29 -39.91 -26.60 -23.85 -19.29 -18.36 -18.02 -16.08 -14.54 -19.93 -23.93 -27.91 -32.83 -32.31 -35.58 -40.66 -46.75 -46.25 -49.61 -46.07 -44.31 -47.63 -46.81 -56.44 -63.63 -13.98 -18.11 -19.13

ROCE %

-91.90 -104.65 -122.70 -92.05 -103.31 -89.04 -72.24 -50.56 -68.98 -76.15 -75.92 -63.61 -75.64 -69.24 -67.36 -45.13 -90.68 -124.19 -121.84 -75.62 -153.62 -186.07 -185.73 -106.08 -118.56 -53.03 -53.18 -37.90 -48.83 -47.29 -41.56 -25.60 -39.36 -42.19 -46.12 -38.23 -71.31 -90.62 -113.93 -105.77 -130.21 -121.57 -100.09 -53.46 -97.85 -117.79 -154.05 -127.93 -44.38 -49.76 -33.79

Current Ratio

1.2 1.2 1.2 1.2 1.2 - 1.4 1.5 1.6 1.4 1.4 1.5 1.5 1.5 1.5 2.3 2.3 2.3 2.3 1.8 1.8 1.8 1.8 2.3 2.3 2.3 2.3 - - - - - - - - - - - - - - - - - - - - - - - -

DSO

60.4 63.7 71.1 - 29.2 29.6 60.9 - 57.7 55.5 63.1 60.7 63.5 68.7 60.5 54.9 62.3 68.8 74.0 61.4 97.3 94.0 85.9 - 79.4 120.7 117.8 - - - - - - - - - 119.6 49.3 112.2 - 2533.9 - - - 16.0 27.7 48.5 - 79.4 113.9 -

DIO

496.9 392.4 334.0 - 45.1 135.4 307.8 - 180.1 233.5 267.6 - 212.5 267.3 233.9 - 229.0 238.7 252.4 - 177.6 244.2 227.0 - 235.7 397.6 473.3 - - - - - - - - - - - - - - - - - - - - - - - -

DPO

168.2 192.7 265.4 - 40.9 127.5 267.3 - 149.2 162.6 231.5 - 185.4 233.2 270.1 - 354.2 369.3 318.7 - - - 137.3 - - - 759.7 - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

557.3 456.1 405.1 - 74.3 165.0 368.7 - 237.8 289.0 330.7 60.7 275.9 336.0 294.4 54.9 291.2 307.6 326.4 61.4 274.9 338.3 312.9 - 315.1 518.2 591.1 - - - - - - - - - 119.6 49.3 112.2 - 2533.9 - - - 16.0 27.7 48.5 - 79.4 113.9 -

Финансовый цикл

389.1 263.4 139.7 - 33.4 37.5 101.3 - 88.6 126.3 99.3 60.7 90.6 102.8 24.3 54.9 -63.0 -61.8 7.7 61.4 274.9 338.3 175.7 - 315.1 518.2 -168.6 - - - - - - - - - 119.6 49.3 112.2 - 2533.9 - - - 16.0 27.7 48.5 - 79.4 113.9 -

Все данные представлены в валюте USD